Walker et al 2015 – Universal Framework for the Benefit-Risk Assessment of Medicines

A universal framework for the evaluation of the benefit-risk assessment of medicines during development by pharmaceutical companies and in the regulatory review by regulatory authorities is considered of value, [...]

2020-07-22T10:41:37+00:00January 22nd, 2015|Tags: , |